New skin patch SFG-02 passes first safety check in healthy volunteers
NCT ID NCT07167914
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 18 times
Summary
This early-stage study tested a new medicated skin patch called SFG-02 in 32 healthy Japanese and White adults aged 18 to 45. The goal was to see if the patch is safe and how the body absorbs and processes the drug. No treatment was given for any disease, so the study only gathered basic safety and drug-level information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sumida Hospital
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.